CAPABLE: FINDINGS, COST SAVINGS, AND SCALING FROM AN AGING-IN-PLACE DEMONSTRATION
نویسندگان
چکیده
منابع مشابه
Can Aging in Place Be Cost Effective? A Systematic Review
PURPOSE OF THE STUDY To systematically review cost, cost-minimization and cost-effectiveness studies for assisted living technologies (ALTs) that specifically enable older people to 'age in place' and highlight what further research is needed to inform decisions regarding aging in place. DESIGN People aged 65+ and their live-in carers (where applicable), using an ALT to age in place at home o...
متن کاملCost-Savings From an Antipsychotic Tablet-Splitting Program.
BACKGROUND Newer atypical antipsychotics such as aripiprazole (Abilify, Otsuka) and lurasidone (Latuda, Sunovion) have favorable safety and efficacy profiles, but their use is limited by high cost. University Hospitals Richmond Medical Center initiated an antipsychotic tablet-splitting program in August 2015 to counter the costs based on the identical pricing structure of aripiprazole and luras...
متن کاملTigerPlace: an innovative 'aging in place' community.
As part of its Raise the Voice campaign to showcase nurses who are key players in transforming health care, the American Academy of Nursing has identified nurses they call edge runners--"practical innovators who have led the way in bringing new thinking and new methods to a wide range of health care challenges." With this article on Marilyn Rantz, a 2008 edge runner for the "Aging in Place Proj...
متن کاملAging in place: From theory to practice
The rapid aging of many Western societies has compelled policymakers and professionals to develop concepts, programs, and services to meet the complex and diverse needs of their elderly populations, in particular the segment of older persons who are frail, chronically ill, and functionally disabled. Aging-in-place has become a key and guiding strategy in addressing and meeting the needs of olde...
متن کاملEstimating Cost Savings from Early Cancer Diagnosis
We estimate treatment cost-savings from early cancer diagnosis. For breast, lung, prostate and colorectal cancers and melanoma, which account for more than 50% of new incidences projected in 2017, we combine published cancer treatment cost estimates by stage with incidence rates by stage at diagnosis. We extrapolate to other cancer sites by using estimated national expenditures and incidence ra...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Innovation in Aging
سال: 2017
ISSN: 2399-5300
DOI: 10.1093/geroni/igx004.5122